Jasper Therapeutics, Inc.
JSPRW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Other share classesJSPR
Q4 2021 vs. Q3 2021
How the institutions holding Jasper Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 16 | 1 | 16 | +1 |
| Shares | 1.88M | 125.0K | 1.45M | −305.6K (−17.4%) |
| Value | $3.67M | $178.0K | $2.97M | −$522.0K (−14.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ionic Capital Management LLC | 338,676 | $498.0K | 0.09% |
| Privium Fund Management B.V. | 98,011 | $153.0K | 0.03% |
| Integrity Capital Management (HK) Ltd | 50,000 | $74.0K | 0.24% |
| Equitec Proprietary Markets, LLC | 45,856 | $67.0K | 0.04% |
| Wolverine Asset Management LLC | 8,394 | $12.0K | 0.00% |
| UBS Group AG | 4,762 | $7.00K | 0.00% |
| SkyView Investment Advisors, LLC | 2 | $0 | 0.00% |
Sold out (6)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| UBS Oconnor LLC | 179,723 | $256.0K |
| Maven Securities LTD | 100,000 | $148.0K |
| Bulldog Investors, LLP | 47,887 | $71.0K |
| Captrust Financial Advisors | 11,988 | $18.0K |
| Cowen and Company, LLC | 10,200 | $15.0K |
| Easterly Investment Partners LLC | 10,000 | $15.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Zazove Associates LLC | 124,993 | $178.0K |